Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease

Clinical trial NCT00010387 · COMPLETED

Trial details

NCT number: NCT00010387
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anemia, Hemolytic, Autoimmune Felty Syndrome Purpura, Thrombocytopenic Autoimmune Diseases

Start date: 1999-03-01
Primary completion: 2007-08-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.